文献速递青光眼白内障与屈光手术

原发性房角关闭行超声乳化联合或不联合房角分离术后房水流出易度:一项随机对照研究

Aqueous outflow facility after phacoemulsification with or without goniosynechialysis in primary angle closure: a randomised controlled study.
PubMed 文献 · Br J Ophthalmol · 2016-10-17

前瞻性随机预试验纳入26例使用青光眼药物、周边前粘连≥90°且有明显晶状体混浊的原发性房角关闭或原发性房角关闭青光眼患者,1:1随机接受单纯超声乳化联合人工晶状体植入或联合房角分离。术后6个月,联合房角分离组房水流出易度和眼压下降幅度均优于单纯超声乳化组,且仅联合组减少降眼压药物使用和周边前粘连范围。

要点

  • 房角分离联合超声乳化组房水流出易度从0.099±0.07升至0.194±0.07 μL/min/mm Hg(p=0.0006),单纯超声乳化组无显著变化。
  • 联合组眼压下降46.0%,单纯超声乳化组下降27.6%(p=0.04),两组眼压均下降。
  • 仅联合组降眼压药物使用从0.923±0.86种降至0.384±0.18种(p=0.0279),周边前粘连从249.2±83.4°降至110.8±53.9°。

核心结论

  • 在此预试验中,随机分配至两种手术组的眼在6个月时结局相似且良好,但仅接受房角分离联合标准超声乳化眼的房水流出易度显著增加、降眼压药物依赖和周边前粘连显著减少。
  • 作者认为此类患者应考虑行房角分离。

研究设计与样本

  • 前瞻性随机预试验,纳入26例使用青光眼药物、周边前粘连≥90°且有明显晶状体混浊的原发性房角关闭或原发性房角关闭青光眼患者。
  • 患者按1:1随机接受单纯超声乳化联合人工晶状体植入(单纯超声乳化组)或超声乳化联合人工晶状体植入加房角分离(联合组)。

主要发现

  • 14例随机分配至联合组,12例分配至单纯超声乳化组。
  • 联合组房水流出易度从0.099±0.07 μL/min/mm Hg增至0.194±0.07 μL/min/mm Hg(p=0.0006),单纯超声乳化组无显著变化。
  • 两组眼压均下降,联合组下降46.0%,单纯超声乳化组下降27.6%(p=0.04)。
  • 术后6个月,仅联合组降眼压药物使用从0.923±0.86种降至0.384±0.18种(p=0.0279),周边前粘连从249.2±83.4°降至110.8±53.9°。
  • 两组均未发生严重不良事件。

临床怎么用

  • 作者认为,对于使用青光眼药物、周边前粘连≥90°且有明显晶状体混浊的原发性房角关闭或原发性房角关闭青光眼患者,应考虑行房角分离联合标准超声乳化。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Goniosynechialysis (GSL) to remove peripheral anterior synechiae (PAS) alongside standard cataract surgery has potential theoretical advantages, Published randomised trials, however, have not shown conclusive functional benefits and aqueous outflow changes following GSL are unknown. This study aimed to compare electronic Shiøtz tonographic aqueous outflow facility (TOF) following phacoemulsification with or without GSL in patients with primary angle closure (PAC) and PAC glaucoma. Secondary outcomes were changes in intraocular pressure (IOP) and use of glaucoma medications. METHODS: Prospective randomised pilot study of 26 patients on glaucoma medication, with ≥90° PAS and significant lens opacity. Patients were randomised 1:1 to receive phacoemulsification with intraocular lens (IOL) implantation only (phaco) or phacoemulsification with IOL plus GSL (phaco-GSL). RESULTS: Fourteen patients were randomised to phaco-GSL and 12 to phaco alone. TOF increased with phaco-GSL from 0.099±0.07 μL/min/mm Hg to 0.194±0.07, μL/min/mm Hg, p=0.0006, while the phaco group showed no significant change. IOP reduced in both groups, but reduced significantly more following phaco-GSL (46.0%) compared with phaco alone (27.6%, p=0.04). Medication use and extent of PAS only reduced with phaco-GSL, from 0.923±0.86 to 0.384±0.18 medications, p=0.0279, and from 249.2±83.4 to 110.8±53.9° PAS, 6 months postoperatively. No serious adverse events occurred in either group. CONCLUSIONS: Eyes randomised to both surgical groups had similar and good outcomes at 6 months in this pilot study. However, only eyes undergoing GSL combined with standard phacoemulsification had significantly increased TOF, reduced glaucoma medication dependence and PAS postoperatively. GSL should therefore be considered in such patients. TRIAL REGISTRATION NUMBER: NCT00719290, Results.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Rodrigues IA, Alaghband P, Beltran Agullo L, et al. Aqueous outflow facility after phacoemulsification with or without goniosynechialysis in primary angle closure: a randomised controlled study. Br J Ophthalmol. 2016. PMID: 28400374. doi:10.1136/bjophthalmol-2016-309556

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。